Ligand Pharmaceuticals | 营业费用

Operating Expenses 更改 日
Amgen USD 6.46B 469M 2024-03
Arrowhead Research USD 126.19M 13.9M 2024-03
Baxter International USD 3.37B 213M 2024-03
Bristol-Myers Squibb USD 10.35B 728M 2024-03
Eli Lilly USD 6.03B 933.2M 2024-03
Gilead Sciences USD 6.88B 1.37B 2024-03
GlaxoSmithKline GBP 5.87B 1.61B 2024-03
Glaxosmithkline GBP 5.87B 1.61B 2024-03
Insmed USD 232.9M 29.06M 2024-03
Ionis Pharmaceuticals USD 269.01M 34.82M 2024-03
Ligand Pharmaceuticals USD 27.99M 3.57M 2024-03
MacroGenics USD 62.85M 2.78M 2024-03
Merck USD 10.02B 6.55B 2024-03
Pacira USD 152M 3.93M 2024-03
Pfizer USD 10.68B 10.12B 2024-03
Veracyte USD 100.5M 33.2M 2024-03



Ligand Pharmaceuticals 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.